losartan has been researched along with trinitrobenzenesulfonic acid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, Y; Wang, XP; Wu, K; Wu, L; Zhang, R | 1 |
| Inokuchi, Y; Kawana, I; Kihara, M; Morohashi, T; Nagashima, Y; Umemura, S | 1 |
| Goldin, E; Israeli, E; Latella, G; Lysy, J; Metanes, I; Necozione, S; Papo, O; Pines, M; Wengrower, D; Zanninelli, G | 1 |
| Liu, TJ; Shi, YY; Wang, EB; Zhao, Q; Zhu, T | 1 |
4 other study(ies) available for losartan and trinitrobenzenesulfonic acid
| Article | Year |
|---|---|
Angiotensin II mediates acinar cell apoptosis during the development of rat pancreatic fibrosis by AT1R.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Disease Models, Animal; Fibrosis; Gene Expression Regulation; In Situ Nick-End Labeling; Losartan; Male; Pancreas; Pancreatic Ducts; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; Trinitrobenzenesulfonic Acid | 2004 |
Amelioration of 2,4,6-trinitrobenzene sulphonic acid induced colitis in angiotensinogen gene knockout mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Colitis; Colon; Cytokines; Immunity, Mucosal; Intestinal Mucosa; Losartan; Male; Mice; Mice, Inbred ICR; Mice, Knockout; Renin-Angiotensin System; Trinitrobenzenesulfonic Acid; Weight Loss | 2005 |
Losartan reduces trinitrobenzene sulphonic acid-induced colorectal fibrosis in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Colitis; Disease Models, Animal; Disease Progression; Down-Regulation; Fibrosis; Intestinal Mucosa; Losartan; Male; Rats; Transforming Growth Factor beta1; Trinitrobenzenesulfonic Acid | 2012 |
AT1R blocker losartan attenuates intestinal epithelial cell apoptosis in a mouse model of Crohn's disease.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Crohn Disease; Cytokines; Disease Models, Animal; Epithelial Cells; Inflammation Mediators; Intestinal Mucosa; Intestines; Losartan; Male; Mice, Inbred C57BL; Permeability; Trinitrobenzenesulfonic Acid; Up-Regulation | 2016 |